Skip to main content

Advertisement

Log in

Association of Serum Zinc and Vitamin A Levels with Severity of Retinopathy in Type 2 Diabetic Patients: a Cross-Sectional Study

  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Diabetic retinopathy (DR) is a common microvascular disorder which occurs in type 2 diabetes mellitus (T2DM) patients due to chronic hyperglycemia. Previous studies reported that serum zinc (Zn) and vitamin A levels were associated with certain diabetic microvascular complications. However, the relationship between Zn and vitamin A levels with the severity of DR in type 2 diabetic patients is not clear. We aimed to analyze the relationship between serum Zn and vitamin A levels with the severity of DR in T2DM. Sixty T2DM patients were selected from whom attending to the ophthalmology center of hospital from June 2017 and Feb 2018. Patients were categorized as controls, non-proliferative DR (NPDR), and proliferative DR (PDR). Anthropometric, dietary, and physical activity data were gathered. Fasting blood samples were taken to measure biochemical parameters. Serum Zn and vitamin A levels were measured via enzymatic-calorimetric and HPLC methods, respectively. Results showed that serum Zn and vitamin A levels were significantly lower in the PDR group than the controls (p = 0.03 and p = 0.008, respectively). Serum low-density lipoprotein (LDL.C) was significantly higher in the PDR than the control group (p = 0.02). Adjusting for the other variables, increase in serum Zn and vitamin A levels reduced risk of DR by 25.7% and 31.1%, respectively (p = 0.02 and p = 0.007). Higher serum LDL.C increased DR severity by 28.7%, adjusted for the variables (95% CI = 0.002, 0.02; p = 0.01). Lower serum Zn and vitamin A levels, as well as higher LDL.C in the T2DM patients, are related to DR severity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. National estimates and general information on diabetes and prediabetes in the United States, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2011

  2. Klein R, Klein BE, Moss SE et al (1998) The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105(10):1801–1815

    Article  CAS  Google Scholar 

  3. Maroufizadeh S, Almasi-Hashiani A, Hosseini M, Sepidarkish M, Omani Samani R (2017) Prevalence of diabetic retinopathy in Iran: a systematic review and meta-analysis. Int J Ophthalmol 10(5):782–789

    PubMed  PubMed Central  Google Scholar 

  4. Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376(9735):124–136

    Article  Google Scholar 

  5. Powell SR (2000) The antioxidant properties of zinc. J Nutr 130:1447S–1454S

    Article  CAS  Google Scholar 

  6. Zienab M, Anhar O, Gomaa M et al (2004) Association between retinol metabolism and diabetic retinopathy. Pol J Food Nutr Sci 13(4):391–396

    Google Scholar 

  7. Erikstrup C, Mortensen OH, Nielsen AR, Fischer CP, Plomgaard P, Petersen AM, Krogh-Madsen R, Lindegaard B, Erhardt JG, Ullum H, Benn CS, Pedersen BK (2009) RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes. Diabetes Obes Metab 11:204–212

    Article  CAS  Google Scholar 

  8. Wang H, Chu W, Hemphill C, Hasstedt SJ, Elbein SC (2002) Mutation screening and association of human retinoid X receptor gamma variation with lipid levels in familial type 2 diabetes. Mol Genet Metab 76:14–22

    Article  CAS  Google Scholar 

  9. Prasad AS (2008) Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 43(5):370–377

    Article  CAS  Google Scholar 

  10. Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA (2003) Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22(4):316–321

    Article  CAS  Google Scholar 

  11. Mousavi SN, Faghihi A, Motaghinejad M et al (2018) Zinc and selenium co-supplementation reduces some lipid peroxidation and angiogenesis markers in a rat model of NAFLD-fed high fat diet. Biol Trace Elem Res 181(2):288–295

    Article  CAS  Google Scholar 

  12. Adachi Y, Yoshida J, Kodera Y, Kiss T, Jakusch T, Enyedy EA, Yoshikawa Y, Sakurai H (2006) Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem Biophys Res Commun 351(1):165–170

    Article  CAS  Google Scholar 

  13. Alscher DM, Braun N, Biegger D et al (2005) Induction of metallothionein in proximal tubular cells by zinc and its potential as an endogenous antioxidant. Kidney Blood Press Res 28(3):127–133

    Article  CAS  Google Scholar 

  14. Ugarte M, Grime GW, Lord G, Geraki K, Collingwood JF, Finnegan ME, Farnfield H, Merchant M, Bailey MJ, Ward NI, Foster PJ, Bishop PN, Osborne NN (2012) Concentration of various trace elements in the rat retina and their distribution in different structures. Metallomics 4(12):1245–1254

    Article  CAS  Google Scholar 

  15. Bok D (1985) Retinal photoreceptor-pigment epithelium interactions. Invest Ophthalmol Vis Sci 26(12):1659–1694

    CAS  PubMed  Google Scholar 

  16. Booth ML, Ainsworth BE, Pratt MI et al (2003) International physical activity questionnaire: 12–country reliability and validity. Med Sci Sports Exerc 195(9131/03):1381–1395

    Google Scholar 

  17. Kowluru RA, Kennedy A (2001) Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Investig Drugs 10(9):1665–1676

    Article  CAS  Google Scholar 

  18. Moustafa SA (2004) Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicol Appl Pharmacol 201(2):149–155

    Article  CAS  Google Scholar 

  19. Ansari NH, Zhang W, Fulep E et al (1998) Prevention of pericyte loss by trolox in diabetic rat retina. J Toxicol Environ Health A 54(6):467–475

    Article  CAS  Google Scholar 

  20. Kowluru RA, Engerman RL, Case GL et al (2001) Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 38(5):385–390

    Article  CAS  Google Scholar 

  21. Obrosova IG, Minchenko AG, Marinescu V et al (2001) Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44(9):1102–1110

    Article  CAS  Google Scholar 

  22. Agardh CD, Agardh E, Hultberg B et al (1998) The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. Curr Eye Res 17(3):251–256

    Article  CAS  Google Scholar 

  23. Kowluru RA, Engerman RL, Kern TS (2000) Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Curr Eye Res 21(4):814–819

    Article  CAS  Google Scholar 

  24. Woollard ACS, Bascal ZA, Armstrong GR et al (1990) Abnormal redox status without increased lipid peroxidation in sugar cataract. Diabetes 39(11):1347–1352

    Article  CAS  Google Scholar 

  25. Morrison SA, Russell RM, Carney EA et al (1978) Zinc deficiency: a cause of abnormal dark adaptation in cirrhotics. Am J Clin Nutr 31(2):276–281

    Article  CAS  Google Scholar 

  26. Afridi HI, Kazi TG, Kazi N et al (2011) Evaluation of status of zinc, copper, and iron levels in biological samples of normal children and children with night blindness with age groups of 3–7 and 8–12 years. Biol Trace Elem Res 142:323–334

    Article  CAS  Google Scholar 

  27. Mochizuki K, Murase H, Imose M, Kawakami H, Sawada A (2006) Improvement of scotopic electroretinograms and night blindness with recovery of serum zinc levels. Jpn J Ophthalmol 50(6):532–536

    Article  CAS  Google Scholar 

  28. Luo Y, Zhao J, Han X et al (2015) Relationship between serum zinc level and microvascular complications in patients with type 2 diabetes. Chin Med J 128(24):3276–3282

    Article  Google Scholar 

  29. Clermont AC, Aiello LP, Mori F et al (1997) Vascular endothelial growth factor and grade of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 124(4):433–446

    Article  CAS  Google Scholar 

  30. Wang X, Wang G, Wang Y (2009) Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy. Am J Ophthalmol 148(6):883–889

    Article  CAS  Google Scholar 

  31. Adamis AP, Miller JW, Bernal MT et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118(4):445–450

    Article  CAS  Google Scholar 

  32. Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18(6):502–508

    Article  Google Scholar 

  33. Adachi T, Teramachi M, Yasuda H, Kamiya T, Hara H (2012) Contribution of p38 MAPK, NF-휅B and glucocorticoid signaling pathways to ER stress-induced increase in retinal endothelial permeability. Arch Biochem Biophys 520(1):30–35

    Article  CAS  Google Scholar 

  34. Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J, Cao J, Noronha G, Yee S, Weis S, Martin MB, Soll R, Cheresh DA, Friedlander M (2008) Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J Clin Invest 118(6):2337–2346

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Kim J, Kim KM, Kim CS, Sohn E, Lee YM, Jo K, Kim JS (2012) Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidaserelated oxidative stress. Free Radic Biol Med 53(2):357–365

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Authors are very thankful to all patients who participated in the present study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seyedeh Neda Mousavi.

Ethics declarations

Ethical approval was obtained from the Ethical Committee of Zanjan University of Medical Sciences, Zanjan, Iran. The present study has been performed in accordance with the ethical standards as laid down in the Declaration of Helsinki.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

rostamkhani, H., Mellati, A.A., Tabaei, B.S. et al. Association of Serum Zinc and Vitamin A Levels with Severity of Retinopathy in Type 2 Diabetic Patients: a Cross-Sectional Study. Biol Trace Elem Res 192, 123–128 (2019). https://doi.org/10.1007/s12011-019-01664-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12011-019-01664-z

Keywords

Navigation